Literature DB >> 2924605

Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep.

E C Fletcher1, R A Luckett, T Miller, C Costarangos, N Kutka, J G Fletcher.   

Abstract

Nonapneic, nocturnal oxyhemoglobin desaturation (NOD) during rapid-eye-movement (REM) sleep has been proposed as a predecessor and possible etiologic factor in the development of pulmonary hypertension in patients both with restrictive and obstructive chronic lung disease. The association between abnormal waking cardiopulmonary hemodynamics and NOD has not been established in patients with mild daytime hypoxemia. Gas exchange, pulmonary function, red cell mass, radionuclide gated cardiac ejection fraction, and supine cardiopulmonary hemodynamics were examined in 36 patients with chronic lung disease. All had a daytime PaO2 greater than 60 mm Hg and REM sleep-related NOD for greater than 5 minutes, to 85 percent or lower. These data were compared to those from 13 subjects with similar symptoms and objective measures of pulmonary dysfunction but without evidence of NOD. Patients with NOD showed more end organ evidence of hypoxemia and more abnormal cardiopulmonary hemodynamics than patients with similar degrees of lung disease but without NOD. The relative role of daytime vs nocturnal hypoxemia in inducing hemodynamic differences between groups cannot be determined from this study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2924605     DOI: 10.1378/chest.95.4.757

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

Review 1.  Are sleep studies necessary in COPD?

Authors:  N J Douglas
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.

Authors:  Xavier Soler; Eduardo Gaio; Frank L Powell; Joe W Ramsdell; Jose S Loredo; Atul Malhotra; Andrew L Ries
Journal:  Ann Am Thorac Soc       Date:  2015-08

Review 3.  Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

4.  Insomnia in patients with COPD.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Pooja Budhiraja; Michael P Habib; Christopher Wendel; Stuart F Quan
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

Review 5.  Sleep-related breathing disorders. 7. Sleep and breathing problems in general medicine.

Authors:  P M Calverley
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

Review 6.  Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial.

Authors:  James K Stoller; Ralph J Panos; Samuel Krachman; Dennis E Doherty; Barry Make
Journal:  Chest       Date:  2010-07       Impact factor: 9.410

Review 7.  Sleep abnormalities and treatment in emphysema.

Authors:  Samuel Krachman; Omar A Minai; Steven M Scharf
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

8.  Nocturnal oxygen saturation and sleep quality in patients with advanced chronic obstructive pulmonary disease during treatment with moderate dose CR-theophylline.

Authors:  P E Brander; T Salmi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 9.  Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 10.  Respiratory disorders during sleep in chronic obstructive pulmonary disease.

Authors:  Oreste Marrone; Adriana Salvaggio; Giuseppe Insalaco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.